Indian drugmaker Glenmark Life Sciences posted a fall in second-quarter profit on Thursday, hurt by the temporary closure of a manufacturing facility in the western state of Gujarat.

Glenmark Pharmaceuticals Ltd share price was down by -1.30% from the previous closing price of ₹1,804.90. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

Glenmark Pharma share price target 2024: Brokerage house Motilal Oswal has revised its ratings for Glenmark Pharma. It has upgraded its ratings for the firm from "Neutral" to a "Buy," increasing ...

Glenmark Life Sciences Limited is an India-based developer and manufacturer of non-commoditized, active pharmaceutical ingredients (APIs) in chronic therapeutic areas. The Company is providing ...

operating in the sector and classified as a on the bse, currently has its share price at The stock has experienced fluctuations today, with a low of ₹ and a high of ₹ Over the past 52 weeks ...

India's generic drugmaker Glenmark Pharmaceuticals reported a loss in the second quarter, hurt by exceptional costs related to a legal settlement and higher expenses. Glenmark incurred an ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The government alleged that between 2013 and 2015, Glenmark paid and received compensation prohibited by the Anti-Kickback Statute.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...